March 23, 2020 / 8:59 AM / 13 days ago

BRIEF-Crossject Buys Development And Marketing Rights For ZENEO® Adrenaline

March 23 (Reuters) - CROSSJECT SA:

* ANNOUNCED ON FRIDAY IT BOUGHT THE DEVELOPMENT AND MARKETING RIGHTS FOR ZENEO® ADRENALINE

* RIGHTS AGREEMENT, WITH NO CASH CONSIDERATION AT SIGNATURE, WILL GIVE RISE TO THE PAYMENT BY CROSSJECT OF ROYALTIES CALCULATED ON THE BASIS OF A SINGLE-DIGIT PERCENTAGE OF PRODUCT SALES BY CROSSJECT

* THE AGREEMENT DOES NOT PROVIDE FOR REIMBURSEMENT OF THE MILLION EUROS RECEIVED BY CROSSJECT AT THE SIGNING OF THE CONTRACT IN 2013

* AGREEMENT INCREASES THE COMMERCIAL AND ECONOMIC POTENTIAL FOR CROSSJECT AND OPENS UP THE POSSIBILITY OF SIGNING NEW AGREEMENTS WITH UPFRONT IN THE MEDIUM TERM

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below